Newsroom
Sorted by: Latest
-
Nalgene Outdoor Surpasses $1.2 Million in Water Access Impact, Expands Commitment on World Water Day
ROCHESTER, N.Y.--(BUSINESS WIRE)--In America, where refillable water bottles are common, more than 2 million people still lack clean running water at home. To help close that gap, Nalgene Outdoor, maker of reusable water bottles, is expanding its commitment to domestic water access after surpassing $1.2 million in funding and in-kind support since launching the Nalgene Water Fund in 2019. The Fund is committing $50,000 to DigDeep, a national nonprofit advancing equitable water access, matching...
-
Tanahashi Prize Recognizes the Robust Long-Term Operation of the 10MW Alkaline-Water Electrolysis System by Asahi Kasei
TOKYO--(BUSINESS WIRE)--Six engineers from Asahi Kasei were awarded the Tanahashi Prize for their contributions to the development of an alkaline-water electrolysis system....
-
LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the treatment of adult patients with moderate to severe Obstructive Sleep Apnea (OSA). The System utilizes proximal hypoglossal nerve stimulation (p-HGNS), a differentiated neurostimulation modality, to treat OSA in patients with an apnea-hypopnea index (AHI) between 15 and 65...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest S&P 500 Dividend Aristocrats Target Income UCITS ETF 18.03.2026 KNG.LN IE000SNMGYT5 600,002.00 USD 12,123,898.40 20.206 ...
-
Tradeweb Builds on Algorithmic Execution Offering for U.S. Treasuries
NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today announced the expansion of its dealer algorithmic execution offering for U.S. Treasuries, adding strategies from Citi and RBC Capital Markets to its suite. This strategic expansion builds on the successful U.S. launch of Tradeweb’s dealer algorithmic execution capabilities last year and further reinforces Tradeweb’s ongoing commitment to providing institutional client...
-
Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting radioantibodies for the treatment of prostate cancer, today announced the appointment of Michael Rossi to its Board of Directors. Mr. Rossi brings more than 30 years of experience in radiopharmaceuticals, drug development, and commercial leadership to Convergent, as the Company completes its Phase 2 study of CONV01-α, a prostate specific membrane anti...
-
Fidelity Investments® Study: 72% of Americans Say They Will Retire on Their Own Terms as They Embrace a New Playbook
BOSTON--(BUSINESS WIRE)--Fidelity Investments® today released its 2026 State of Retirement Planning Study, revealing Americans are increasingly redefining retirement, as nearly 7-in-10 are considering a non-traditional approach to the next chapter of their lives. Encouragingly, the general outlook on retirement prospects is also trending in a positive direction, with 72% expecting to retire on their own terms, up five percentage points from last year. The increase is driven in part by a renewed...
-
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an update on its ongoing regulatory interactions with the U.S. Food and Drug Administration (FDA) regarding AMONDYS 45® (casimersen) and VYONDYS 53® (golodirsen) for the treatment of Duchenne muscular dystrophy (DMD). Sarepta requested a meeting with FDA to discuss submitting supplemental new drug applications (sNDA) seeking conversion of the ac...
-
Beretta Holding Sends Letter to Ruger Shareholders Highlighting the Urgent Need for Boardroom Change
LUXEMBOURG--(BUSINESS WIRE)--Beretta Holding S.A. (“Beretta Holding” or “we”), a family-owned group leading the global premium light firearms, optics and ammunition industry and the largest shareholder of Sturm, Ruger & Company, Inc. (“Ruger” or the “Company”), with 9.95% ownership of the Company’s outstanding common stock, today sent a letter to Ruger shareholders detailing the urgent need for Board change at the Company in order to restore value for all shareholders. The letter highlights...
-
SolarEdge Launches its Next-Generation SolarEdge Nexis Residential Solar & Storage System in Germany
MILPITAS, Calif. & MUNICH--(BUSINESS WIRE)--SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (Nasdaq: SEDG), a global leader in smart energy technology, today announces the much-anticipated commercial launch of its next-generation three-phase SolarEdge Nexis system in Germany. Now available for order, SolarEdge Nexis features an entirely new design concept from inverter to battery – allowing homeowners to easily add storage capacity in small steps to match energy needs (from 4.9kW th...